Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
217.50    1.00 (0.46%)
Bid:
215.00
Ask:
220.00
Spread: 5.00 (2.326%)
Market Cap: £148.65m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Quarterly Syndicate Mid-point Forecasts

1 Apr 2021 07:00

RNS Number : 2127U
Helios Underwriting Plc
01 April 2021
 

1st April 2021

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Quarterly Syndicate Mid-point Forecasts

 

Helios, the unique investment vehicle which acquires and consolidates private underwriting capacity at Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2018 and 2019 years of account based on 4th quarter 2020 estimates.

 

Nigel Hanbury, Chief Executive, commented:

 

"As the only listed consolidator of private capital at Lloyd's, Helios offers a unique opportunity for growth and returns from exposure to the Lloyd's market through targeted acquisition of the capacity of the better quality syndicates. Our strategy is bringing results, with returns on average 5.7% better than the Lloyd's market itself over recent years.

 

"Following our recent successful fundraising, we are pursuing opportunities to further build our core portfolio of capacity, to increase the capacity retained by Helios and continue to achieve outperformance against the Lloyd's market as whole.

 

"We look forward to creating further shareholder value."

 

 

Year of Account

 

2018

2019

2020

2021

 

£m

£m

£m

£m

Capacity - Position as at 17th November 2020

 

 

 

 

Retained

27.6

23.3

21.1

 

Reinsured

38.2

39.0

49.1

 

 

65.8

62.2

70.2

 

Capacity acquired since 17th November 2020

 

 

 

 

Retained

8.5

8.0

9.7

 

Reinsured

-

-

-

 

 

 

 

 

 

Capacity - Position as at 31st March 2021

 

 

 

 

Retained

36.1

31.3

30.8

58.6

Reinsured

38.2

39.0

49.1

51.6

 

74.3

70.3

80.0

110.3

 

 

 

 

 

Mid-point forecast at 30th September 2020

-2.10%

-2.60%

 

 

Final result / Current mid-point forecast

-0.30%

-2.15%

 

 

 

 

 

 

 

Lloyd's Market Average

-5.89%

-5.19%

 

 

Helios out performance

5.59%

3.04%

 

 

 

Commentary

 

The 2018 result showed a good improvement over the midpoint forecasts as at 30th September 2020 reflecting the investment returns achieved and the confidence in the old year reserves of the supported syndicates.

 

The outperformance of 5.6% of the portfolio against the average for the Lloyd's market for 2018 continues the trend of outperformance achieved over the last 6 years which averages over 5.7% over the period.

 

The smaller than expected improvement in 2019 midpoint forecast in the quarter reflects the continuing strengthening of the reserves for Covid 19 losses by syndicates.

 

Notes

1) The table above shows the capacity as at 31st March 2021 splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers. 

2) The acquisitions of the Limited Liability Vehicles and capacity acquired was announced on 2nd November 2020 and the acquisitions were completed on 27th November 2020.

3) The mid-point forecasts for 2018 and 2019 years of account as of 4th quarter 2020 have been aggregated at syndicate level from estimates supplied by Managing Agents.

4) The impact on Helios will be as follows:

a. The change in the mid point estimates on the retained capacity over the year will be recognised in the Helios income statement in the year to 31st December 2020.

b. The overall change in the result will be recognised by Helios in cash at the close of the year of account.

 

For further information, please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive 07787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

 

Shore Capital Limited

Robert Finlay 020 7601 6100

David Coaten

 

Willis Re Securities (Financial Adviser)

Alastair Rodger +44 (0)20 3124 6033

Quentin Perrot +44 (0)20 3124 6499  

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £110m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCWPUUGWUPGGRG
Date   Source Headline
21st Apr 20217:00 amRNSDirectorate Changes
20th Apr 202111:35 amRNSHolding(s) in Company
1st Apr 202112:34 pmRNSResult of GM, TVR and Directors' Participation
1st Apr 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
30th Mar 20217:00 amRNSResult of Open Offer
11th Mar 20217:00 amRNSDirector/PCA Shareholding
9th Mar 20217:00 amRNSResult of Placing and Subscription
8th Mar 20214:45 pmRNSFundraising to raise up to approximately £60m
16th Feb 20211:37 pmRNSRevision to Adjusted Net Asset Value
8th Feb 20217:00 amRNSDirectorate Change
2nd Feb 20217:00 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSAppointment of Financial Adviser
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSMaterial Capacity Increase
30th Nov 20209:57 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
26th Nov 20203:40 pmRNSResult of GM, TVR and Directors' Participations
24th Nov 20207:00 amRNSResult of Open Offer
19th Nov 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
2nd Nov 20207:00 amRNSPlacing, Subscription, Open Offer & Acquisitions
7th Oct 20207:00 amRNSProposed Fundraising
25th Sep 20207:00 amRNSHalf-year Report
17th Aug 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
10th Aug 20207:00 amRNSUpdate on Capacity and Growth Plans
25th Jun 202012:38 pmRNSResult of AGM
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 202012:28 pmRNSHolding(s) in Company
1st Jun 20207:30 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSFinal results for the year ended 31 December 2019
30th Mar 20207:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20207:00 amRNSCapacity Update and Transaction in Own Shares
13th Dec 20197:00 amRNSAcquisition
18th Nov 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
7th Oct 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20199:39 amRNSReplacement- Transaction in Own Shares
2nd Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20197:00 amRNSTransaction in Own Shares
16th Aug 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Aug 20194:28 pmRNSHolding(s) in Company
12th Aug 20197:00 amRNSProposed Ordinary Share repurchases
19th Jul 20198:47 amRNSHolding(s) in Company
16th Jul 20191:00 pmRNSResult of Meeting
28th Jun 20193:13 pmRNSResult of AGM
13th Jun 20197:00 amRNSChange of Adviser
13th Jun 20197:00 amRNSFundraising, Acquisition, Waiver & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.